Cardioprotective effect of vanadyl sulfate on ischemia/reperfusion-induced injury in rat heart in vivo is mediated by activation of protein kinase B and induction of FLICE-inhibitory protein

Cardiovascular Therapeutics

Volumn 26, Issue 1, 2008, Pages 10-23

  Bhuiyan, Md Shenuarin ^a   Takada, Yoko ^a   Shioda, Norifumi ^a   Moriguchi, Shigeki ^a   Kasahara, Jiro ^a   Fukunaga, Kohji ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Myocardial ischemia reperfusion; Protein kinase B; Vanadyl sulfate

Indexed keywords

CASPASE 3; CASPASE 9; FAS ANTIGEN; FLICE INHIBITORY PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHRL1; VANADYL SULFATE;

ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; IN VIVO STUDY; LEFT CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOOD PRESSURE; BLOTTING, WESTERN; CARDIOTONIC AGENTS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASES; CELL SURVIVAL; ENZYME ACTIVATION; FAS LIGAND PROTEIN; FORKHEAD TRANSCRIPTION FACTORS; HEART RATE; INJECTIONS, INTRAPERITONEAL; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; ONCOGENE PROTEIN V-AKT; PROTEIN TYROSINE PHOSPHATASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SIGNAL TRANSDUCTION; VANADIUM COMPOUNDS;

EID: 47049094278     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/j.1527-3466.2008.00039.x     Document Type: Article

References (66)

1. Aihara K, Hisa H, Sato T, Yoneyama F, Sasamori J, Yamaguchi F, Yoneyama S, Mizuno Y, Takahashi A, Nagai A (2000) Cardioprotective effect of TY-12533, a novel Na(+)/H(+) exchange inhibitor, on ischemia/reperfusion injury. Eur J Pharmacol 404 : 221 229.
2. Anversa P, Cheng W, Liu Y, Leri A, Redaelli G, Kajstura J (1998) Apoptosis and myocardial infarction. Basic Res Cardiol 93 (suppl 3 8 12.
3. Barceloux DG (1999) Vanadium. J Toxicol Clin Toxicol 37 : 2 265.
4. Bardales RH, Hailey S, Xie SS, Schafer RF, Hsu S-M (1996) In situ apoptosis assay for the detection of early acute myocardial infarction. Am J Pathol 149 : 821 829.
5. Bergamaschi G, Rosti V, Danova M, Ponchio L, Lucotti C, Cazzola M (1993) Inhibitors of tyrosine phosphorylation induce apoptosis in human leukemic cell lines. Leukemia 7 : 2012 2018.
6. Bhanot S, McNeill JH (1994) Vanadyl sulfate lowers plasma insulin and blood pressure in spontaneously hypertensive rats. Hypertension 24 : 625 632.
7. Bhanot S, McNeill JH, Bryer-Ash M (1994) Vanadyl sulfate prevents fructose-induced hyperinsulinemia and hypertension in rats. Hypertension 23 : 308 312.
8. Bhanot S, Michoulas A, McNeill JH (1995) Antihypertensive effects of vanadium compounds in hyperinsulinemic, hypertensive rats. Mol Cell Biochem 153 : 205 209.
9. Bhuiyan S, Fukunaga K (2007) Inhibition of HtrA2/Omi ameliorates heart dysfunction following ischemia/reperfusion injury in rat heart in vivo. Eur J Pharmacol 557 : 168 177.
10. Brichard SM, Henquin JC (1995) The role of vanadium in the management of diabetes. TIPS 16 : 265 270.
11. Brown TJ, Shuford WW, Wang WC, Nadler SG, Bailey TS, Marquardt H, Mittler RS (1996) Characterization of a CD43/leukosialin-mediated pathway for inducing apoptosis in human T-lymphoblastoid cells. J Biol Chem 271 : 27686 27695.
12. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96 : 857 868.
13. Cadene A, Grigorescu F, Serrano J-J, Cros G (1997) Characterization of vanadyl sulfate on vascular contraction: Roles of calcium and tyrosine phosphorylation. J Pharmacol Exp Ther 281 : 491 498.
14. Cam MC, Pederson RA, Brownsey RW, McNeill JH (1993) Long-term effectiveness of oral vanadyl sulphate in streptozotocin-diabetic rats. Diabetologia 36 : 218 224.
15. Cantley LC Jr., Josephson L, Warner R, Yanagisawa M, Lechene C, Guidotti G (1977) Vanadate is a potent (Na,K)-ATPase inhibitor found in ATP derived from muscle. J Biol Chem 252 : 7421 7423.
16. Carmeli C, Tadmor O, Lifshitz Y, Ophir R, Carmel S (1992) Inhibition of chloroplast CF1-ATPase by vanadate. FEBS Lett 299 : 229 230.
17. Clarkson PM, Rawson ES (1999) Nutritional supplements to increase muscle mass. Crit Rev Food Sci Nutr 39 : 4 317.
18. Cohen MV, Yang X-M, Downey JM (1999) Smaller infarct after preconditioning does not predict extent of early functional improvement of reperfused heart. Am J Physiol Heart Circ Physiol 277 : H1754 H1761.
19. Cros G, Mongold JJ, Serrano JJ, Ramanadham S, McNeill JH (1992) Effects of vanadyl derivatives on animal models of diabetes. Mol Cell Biochem 109 : 163 166.
20. Dafnis E, Spohn M, Lonis B, Kurtzman NA, Sabatini S (1992) Vanadate causes hypokalemic distal renal tubular acidosis. Am J Physiol 262 : F449 F453.
21. Dai S, McNeill JH (1994) One-year treatment of non-diabetic and streptozotocin-diabetic rats with vanadyl sulphate did not alter blood pressure or haematological indices. Pharmacol Toxicol 74 : 2 110.
22. Dai S, Vera E, McNeill JH (1995) Lack of haematological effect of oral vanadium treatment in rats. Pharmacol Toxicol 76 : 4 263.
23. Dijkers PF, Medema RH, Lammers JWJ, Koenderman L, Coffer PJ (2000) Expression of the pro-apoptotic Bcl02 family member Bim is regulated by the forkhead transcription factor FKHRL-1. Curr Biol 10 : 1201 1204.
24. Fawcett JP, Farquhar SJ, Walker RJ, Thou T, Lowe G, Goulding A (1996) The effect of oral vanadyl sulfate on body composition and performance in weight-training athletes. Int J Sport Nutr 6 : 4 382.
25. Fawcett JP, Farquhar SJ, Thou T, Shand BI (1997) Oral vanadyl sulphate does not affect blood cells, viscosity or biochemistry in humans. Pharmacol Toxicol 80 : 202 206.
26. Feng Q, Lu X, Jones DL, Shen J, Arnold MO (2001) Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation 104 : 700 704.
27. Fryer RM, Schultz JE, Hsu AK, Gross GJ (1999) Importance of PKC and tyrosine kinase in single or multiple cycles of preconditioning in rat hearts. Am J Physiol 276 : H1229 1235.
28. Gao F, Gao E, Yue TL, Ohlstein EH, Lopez BL, Christopher TA, Ma XL (2002) Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: The roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 105 : 1497 1502.
29. Goldfine AB, Patti M-E, Zuberi L, Goldstein BJ, LeBlanc R, Landaker EJ, Jiang ZY, Willsky GR, Kahn CR (2000) Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: In vivo and in vitro studies. Metabolism 49 : 400 410.
30. Gottilieb RA, Engler RL (1999) Apoptosis in myocardial ischemia-reperfusion. Ann NY Acad Sci 874 : 412 426.
31. Imanishi T, Murry CE, Reinecke H, Hano T, Nishio I, Liles WC, Hofsta L, Kim K, O'Brien KD, Schwartz SM, et al 2000) Cellular FLIP is expressed in cardiomyocytes and down-regulated in TUNEL-positive grafted cardiac tissues. Cardiovasc Res 48 : 101 110.
32. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, et al. 1997) Inhibition of death receptor signals by cellular FLIP. Nature 388 : 190 195.
33. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC, Olivetti G, Anversa P (1996) Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Investig 74 : 86 107.
34. Kawano T, Fukunaga K, Takeuchi Y, Morioka M, Yano S, Hamada J, Ushio Y, Miyamoto E (2001) Neuroprotective effect of sodium orthovanadate on delayed neuronal death after transient forebrain ischemia in gerbil hippocampus. J Cereb Blood Flow Metab 21 : 1268 1280.
35. Kreider RB (1999) Dietary supplements and the promotion of muscle growth with resistance exercise. Sports Medicine 27 : 2 97.
36. LaVoie HA, Witorsch RJ (1995) Investigation of intracellular signals mediating the anti-apoptotic action of prolactin in Nb2 lymphoma cells. Proc Soc Exp Biol Med 209 : 257 269.
37. Liu H, McNeill JH (1994) Effects of vanadium treatment on the alterations of cardiac glycogen phosphorylase and phosphorylase kinase in streptozotocin-induced chronic diabetic rats. Can J Physiol Pharmacol 72 : 1537 1543.
38. Llobet JM, Domingo JL (1984) Acute toxicity of vanadium compounds in rats and mince. Toxicol Lett 23 : 227 231.
39. Matsui T, Tao J, del Monte F, Lee KH, Li L, Picard M, Force TL, Franke TF, Hajjar RJ, Rosenzweig A (2001) Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104 : 330 335.
40. Michael LH, Entman ML, Hartley CJ, Youker KA, Zhu J, Hall SR, Hawkins HK, Berens K, Ballantyne CM (1995) Myocardial ischemia and reperfusion: A novel murine model. Am J Physiol 269 : 2147 2154.
41. Mongold JJ, Cros GH, Vian L, Tep A, Ramanadham S, Siou G, Diaz J, McNeill JH, Serrano JJ (1990) Toxicological aspects of vanadyl sulphate on diabetic rats: Effects on vanadium levels and pancreatic B-cell morphology. Pharmacol Toxicol 67 : 192 198.
42. Nakai M, Watanabe H, Fujiwara C, Kakegawa H, Satoh T, Takada J, Matsushita R, Sakurai H (1995) Mechanism on insulin-like action of vanadyl sulfate: Studies on interaction between rat adipocytes and vanadium compounds. Biol Pharm Bull 18 : 719 725.
43. Nechay BR, Nanninga LB, Nechay PSE, Post RL, Grandham JJ, Macara JG, Kubena LF, Philips TD, Nielsen FH (1986) Role of vanadium in biology. Fed Proc 45 : 123 132.
44. Onai Y, Suzuki J, Kakuta T, Maejima Y, Haraguchi G, Fukasawa H, Muto S, Itai A, Isobe M (2004) Inhibition of IκB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury. Cardiovasc Res 63 : 51 59.
45. Panka DJ, Mano T, Suhara T, Walsh K, Mier JW (2001) Phosphatidylinositol 3-Kinase/Akt Activity Regulates c-FLIP Expression in Tumor Cells. J Biol Chem 276 : 6893 6896.
46. Przyklenk K, Kloner RA (1998) Ischemic preconditioning: Exploring the paradox. Prog Cardiovasc Dis 40 : 517 547.
47. Pytkowski B, Jagodzinska-Hamann L (1996) Effect of in vivo vanadate administration on calcium exchange and contractile force of rat ventricular myocardium. Toxicol Lett 84 : 167 173
48. Ramanadham S, Brownsey RW, Cros GH, Mongold JJ, McNeill JH (1989) Sustained prevention of myocardial and metabolic abnormalities in diabetic rats following withdrawal from oral vanadyl treatment. Metabolism 38 : 1022 1028.
49. Rasper DM, Vaillancourt JP, Hadano S, Houtzager VM, Seiden I, Keen SL, Tawa P, Xanthoudakis S, Nasir J, Martindale D, et al 1998) Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex. Cell Death Differ 5 : 271 288.
50. Ronzani N, Stephan L, Hasselbach W (1991) Pressure effects on the binding of vanadate to the sarcoplasmic reticulum calcium transport enzyme. Eur J Biochem 201 : 265 272.
51. Sakurai H, Shimomura S, Fukuzawa K, Ishizu K (1980) Detection of oxovanadium (IV) and characterization of its ligand environment in subcellular fractions of the liver of rats treated with pentavalent vanadium (V). Biochem Biophys Res Commun 96 : 293 298.
52. Sakurai H, Tsuchiya K, Nukatsuka M, Sofue M, Kawada J (1990) Insulin-like effect of vanadyl ion on streptozotocin-induced diabetic rats. J Endocrinol 126 : 241 459.
53. Skurk C, Maatz H, Kim HS, Yang J, Abid MR, Aird WC, Walsh K (2004) The Akt-regulated forkhead transcription factor FOXO3a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP. J Biol Chem 279 : 1513 1525.
54. Suhara T, Mano T, Oliveira BE, Walsh K (2001) Phosphatidylinositol 3-Kinase/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP). Circ Res 89 : 13 19.
55. Takada Y, Hashimoto M, Kasahara J, Aihara K, Fukunaga K (2004) Cytoprotective effect of sodium orthovanadate on ischemia/reperfusion-induced injury in the rat heart involves Akt activation and inhibition of fodrin breakdown and apoptosis. J Pharmacol Exp Ther 311 : 1249 1255.
56. Takashi E, Ashraf M (2000) Pathologic assessment of myocardial cell necrosis and apoptosis after ischemia and reperfusion with molecular and morphological markers. J Mol Cell Cardiol 32 : 209 224.
57. Tang ED, Nunez G, Barr FG, Guan KL (1999) Negative regulation of the forkhead transcription factor FKHR by Akt. J Biol Chem 274 : 16741 16746.
58. Theberge JF, Mehdi MZ, Pandey SK, Srivastava AK (2003) Prolongation of insulin-induced activation of mitogen-activated protein kinases ERK 1/2 and phosphatidylinositol 3-kinase by vanadyl sulfate, a protein tyrosine phosphatase inhibitor. Arch Biochem Biophys 420 : 9 17.
59. Vahlhaus C, Schulz R, Post H, Rose J, Heusch G (1998) Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and protein tyrosine kinase in pigs. J Mol Cell Cardiol 30 : 197 209.
60. VinÄ als F, Fergus R, McKenzie, Pouysse gur J (2001) Growth factor-stimulated protein synthesis is inhibited by sodium orthovanadate. Eur J Biochem 268 : 2308 2314.
61. Watanabe T, Awane Y, Ikeda S, Fujiwara S, Kubo K, Kikuchi T, Kusumoto K, Wakimasu M, Fujino M (1995) Pharmacology of a non-selective ETA and ETB receptor antagonist, TAK-044 and the inhibition of myocardial infarct size in rats. Br J Pharmacol 114 : 949 954.
62. Waters MD (1977) Toxicology of vanadium. In: Goyer RA, Melhman MA, eds. The toxicology of trace elements, Vol. 2: advances in modern toxicology. New York: Halsted Press, 147 189.
63. Weiss JN, Korge P, Honda HM, Ping P (2003) Role of the mitochondrial permeability transition in myocardial disease. Circ Res 93 : 292 301.
64. Willsky GR, Goldfine AB, Kostyniak PJ, McNeill JH, Yang LQ, Khan HR, Crans DC (2001) Effect of vanadium (IV) compounds in the treatment of diabetes: In vivo and in vitro studies with vanadyl sulfate and bis(maltolato) oxovanadium (IV). J Inorg Biochem 85 : 33 42.
65. Yamashita K, Kajstura J, Discher DJ, Wasserlauf BJ, Bishopric NH, Anversa P, Webster KA (2001) Reperfusion-activated Akt kinase prevent apoptosis in transgenic mouse hearts overexpressing insulin-like growth factor-1. Circ Res 88 : 609 614.
66. Zhao ZQ, Velez DA, Wang NP, Hewan-Lowe KO, Nakamura M, Guyton RA, Vinten-Johansen J (2001) Progressively developed myocardial apoptotic cell death during late phase of reperfusion. Apoptosis 6 : 279 290.